These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 12752181)
1. Treatment of acne with isotretinoin: recommendations based on Australian experience. Cooper AJ; Australas J Dermatol; 2003 May; 44(2):97-105. PubMed ID: 12752181 [TBL] [Abstract][Full Text] [Related]
2. Treatment of an infantile acne with oral isotretinoin. Sarazin F; Dompmartin A; Nivot S; Letessier D; Leroy D Eur J Dermatol; 2004; 14(1):71-2. PubMed ID: 14965803 [TBL] [Abstract][Full Text] [Related]
3. Could higher doses of isotretinoin reduce the frequency of treatment failure in patients with acne? Coloe J; Du H; Morrell DS J Am Acad Dermatol; 2011 Aug; 65(2):422-423. PubMed ID: 21763566 [No Abstract] [Full Text] [Related]
4. The role of isotretinoin in acne therapy: why not as first-line therapy? facts and controversies. Rigopoulos D; Larios G; Katsambas AD Clin Dermatol; 2010; 28(1):24-30. PubMed ID: 20082946 [TBL] [Abstract][Full Text] [Related]
5. Low-dose schema of isotretinoin in acne vulgaris. Mandekou-Lefaki I; Delli F; Teknetzis A; Euthimiadou R; Karakatsanis G Int J Clin Pharmacol Res; 2003; 23(2-3):41-6. PubMed ID: 15018017 [TBL] [Abstract][Full Text] [Related]
6. Fire needle pretreatment with 5-aminolevulinic acid photodynamic therapy combined with low-dose isotretinoin in the treatment of severe refractory nodulocystic acne. Du L; Cao Z; Wei J; Li M; Han C; Zhang C Photodiagnosis Photodyn Ther; 2024 Jun; 47():104215. PubMed ID: 38735352 [TBL] [Abstract][Full Text] [Related]
7. Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Akman A; Durusoy C; Senturk M; Koc CK; Soyturk D; Alpsoy E Arch Dermatol Res; 2007 Dec; 299(10):467-73. PubMed ID: 17710426 [TBL] [Abstract][Full Text] [Related]
8. Guidelines of care for the management of acne vulgaris. Zaenglein AL; Pathy AL; Schlosser BJ; Alikhan A; Baldwin HE; Berson DS; Bowe WP; Graber EM; Harper JC; Kang S; Keri JE; Leyden JJ; Reynolds RV; Silverberg NB; Stein Gold LF; Tollefson MM; Weiss JS; Dolan NC; Sagan AA; Stern M; Boyer KM; Bhushan R J Am Acad Dermatol; 2016 May; 74(5):945-73.e33. PubMed ID: 26897386 [TBL] [Abstract][Full Text] [Related]
9. Roaccutane treatment guidelines: results of an international survey. Cunliffe WJ; van de Kerkhof PC; Caputo R; Cavicchini S; Cooper A; Fyrand OL; Gollnick H; Layton AM; Leyden JJ; Mascaró JM; Ortonne JP; Shalita A Dermatology; 1997; 194(4):351-7. PubMed ID: 9252756 [TBL] [Abstract][Full Text] [Related]
10. Psychological impact of isotretinoin treatment in patients with moderate and severe acne. Simić D; Situm M; Letica E; Penavić JZ; Zivković MV; Tomić T Coll Antropol; 2009 Dec; 33 Suppl 2():15-9. PubMed ID: 20120397 [TBL] [Abstract][Full Text] [Related]
11. Severe acne infantum successfully treated with isotretinoin. Torrelo A; Pastor MA; Zambrano A Pediatr Dermatol; 2005; 22(4):357-9. PubMed ID: 16060877 [TBL] [Abstract][Full Text] [Related]
12. The effect of continuous high versus low dose oral isotretinoin regimens on dermcidin expression in patients with moderate to severe acne vulgaris. El Aziz Ragab MA; Omar SS; Collier A; El-Wafa RAHA; Gomaa N Dermatol Ther; 2018 Nov; 31(6):e12715. PubMed ID: 30397984 [TBL] [Abstract][Full Text] [Related]
14. The use of oral antibiotics before isotretinoin therapy in patients with acne. Nagler AR; Milam EC; Orlow SJ J Am Acad Dermatol; 2016 Feb; 74(2):273-9. PubMed ID: 26525749 [TBL] [Abstract][Full Text] [Related]
15. [Recurrence in patients diagnosed with acne treated by isotretinoin and other methods]. Bergler-Czop B; Brzezińska-Wcisło L Wiad Lek; 2006; 59(3-4):152-7. PubMed ID: 16813256 [TBL] [Abstract][Full Text] [Related]
16. Use of systemic agents in the treatment of acne vulgaris. Johnson BA; Nunley JR Am Fam Physician; 2000 Oct; 62(8):1823-30, 1835-6. PubMed ID: 11057839 [TBL] [Abstract][Full Text] [Related]
20. Isotretinoin treatment in nodulocystic acne with and without polycystic ovary syndrome: efficacy and determinants of relapse. Cakir GA; Erdogan FG; Gurler A Int J Dermatol; 2013 Mar; 52(3):371-6. PubMed ID: 22998438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]